Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Differential Response of FDG Uptake in Pelvic Bone Marrow to Concurrent Chemoradiotherapy

Robinson M. et al, (2021), RADIOTHERAPY AND ONCOLOGY, 161, S1054 - S1055

A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.

Muirhead R. et al, (2020), Clin Oncol (R Coll Radiol), 32, 874 - 883

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma.

Bluemke E. et al, (2020), Clin Transl Radiat Oncol, 22, 44 - 49

A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.

Brown NF. et al, (2020), BMC Cancer, 20

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer.

Robinson M. et al, (2020), Radiother Oncol, 143, 19 - 23

A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus

Muirhead R. et al, (2019)

Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.

McGowan DR. et al, (2019), Eur J Cancer, 113, 87 - 95

Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?

Sabbagh A. et al, (2019), Clin Oncol (R Coll Radiol), 31, 72 - 80

Is there a role for a biological boost in squamous cell anal cancer?

Muirhead R. et al, (2018)

Changes in Pelvic Active Bone Marrow seen on FDG-PET in Patients Receiving Concurrent Chemoradiation for Anal Cancer

Robinson M. et al, (2018)

Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study

McGowan DR. et al, (2018)